Home9PT • FRA
add
Pliant Therapeutics Inc
Previous close
€1.22
Day range
€1.22 - €1.24
Year range
€1.05 - €14.30
Market cap
90.85M USD
Avg Volume
4.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 53.32M | 13.36% |
Net income | -49.73M | -20.98% |
Net profit margin | — | — |
Earnings per share | -0.82 | -18.84% |
EBITDA | -52.86M | -13.50% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 355.72M | -28.03% |
Total assets | 396.95M | -22.49% |
Total liabilities | 92.87M | 140.73% |
Total equity | 304.08M | — |
Shares outstanding | 61.24M | — |
Price to book | 0.24 | — |
Return on assets | -31.64% | — |
Return on capital | -34.61% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -49.73M | -20.98% |
Cash from operations | -47.66M | -89.87% |
Cash from investing | 39.13M | 22.59% |
Cash from financing | 102.00K | -53.42% |
Net change in cash | -8.43M | -219.75% |
Free cash flow | -33.16M | -77.25% |
About
Founded
2015
Headquarters
Website
Employees
171
